Covid-19
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
The trial will assess the pharmacokinetics, safety, and tolerability of S-892216 in healthy adults.
Novavax reports positive results from Phase II study of vaccine candidates
Enanta reports positive data from Phase II Covid-19 therapy trial
WHO declares end of Covid-19 public health emergency
US research centre uses new methods to include rural people in trials
Veru earns FDA go-ahead for new Phase III Covid-19 trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox